Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use

Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use

US Patent 8350019 · Granted Jan 8, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glycoconjugates and their use as potential vaccines against infection by Shigell2019
Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a2018
Glycoconjugates and their use as potential vaccines against infection by Shigell2016
Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a2014
Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their u2013
Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their u2013
Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their u2013
Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from 2012
Glycoconjugates and their use as potential vaccines against infection by Shigell2012
Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their u2011
Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their u2011
Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their u2011